SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Boston Scientific Corp – ‘10-K405’ for 12/31/99 – EX-23.1

On:  Thursday, 3/30/00   ·   For:  12/31/99   ·   Accession #:  950135-0-1894   ·   File #:  1-11083

2 References:   

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of                Filer                Filing    For·On·As Docs:Size              Issuer               Agent

 3/30/00  Boston Scientific Corp            10-K405    12/31/99   10:339K                                   Bowne of Boston/FA

Annual Report — [x] Reg. S-K Item 405   —   Form 10-K
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-K405     Boston Scientific Corporation                         35    162K 
 2: EX-10.20    2000 Long-Term Incentive Plan                          9     48K 
 3: EX-10.30    Employee Agreement - Dr. Mohan                         4     16K 
 4: EX-10.31    Agreement and General Release of All Claims            9     35K 
 5: EX-10.32    Consulting Agreement                                   8     30K 
 6: EX-12.1     Computation of Ratios                                  1      9K 
 7: EX-13.1     1999 Financials From Annual Report                    64±   309K 
 8: EX-21       List of the Company's Subsidiaries                     8     23K 
 9: EX-23.1     Consent of Ernst & Young LLP                           1      8K 
10: EX-27.1     Financial Data Schedule                                1      7K 


EX-23.1   —   Consent of Ernst & Young LLP

EX-23.1TOCTopPreviousNextBottomJust 1st
 

Exhibit 23.1 Consent of Independent Auditors We consent to the incorporation by reference in this Annual Report (Form 10-K) of Boston Scientific Corporation of our report dated February 4, 2000, included in the 1999 Annual Report to Shareholders of Boston Scientific Corporation. Our audits also included the financial statement schedule of Boston Scientific Corporation listed in Item 14(a). This schedule is the responsibility of the Company's management. Our responsibility is to express an opinion based on our audits. In our opinion, the financial statement schedule referred to above, when considered in relation to the basic financial statements taken as a whole, presents fairly in all material respects the information set forth therein. We also consent to the incorporation by reference in the Registration Statements (Forms S-8 Nos. 33-57242, 33-89772, 33-93790, 33-99766, 33-80265, 333-02256, 333-25033, and 333-25037) and in the Registration Statements (Forms S-3 Nos. 333-37255, 333-64887, and 333-64991) of our report dated February 4, 2000, with respect to the consolidated financial statements incorporated herein by reference, and our report included in the preceding paragraph with respect to the financial statement schedule included in this Annual Report (Form 10-K) of Boston Scientific Corporation. ERNST & YOUNG LLP Boston, Massachusetts March 27, 2000

Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘10-K405’ Filing    Date    Other Filings
Filed on:3/30/00
3/27/00
2/4/00
For Period End:12/31/9911-K
 List all Filings 


2 Subsequent Filings that Reference this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 2/23/22  Boston Scientific Corp.           10-K       12/31/21   89:21M
 2/23/21  Boston Scientific Corp.           10-K       12/31/20   87:20M
Top
Filing Submission 0000950135-00-001894   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Tue., May 14, 12:17:13.1pm ET